Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice

Introduction: Treatment-free remission (TFR) is a new goal of chronic myeloid leukemia (CML) therapy. TFR is feasible when the patient has achieved a deep and stable molecular response and met the criteria required to ensure its success. Treatment discontinuation should not be proposed to the CML pa...

Descripció completa

Dades bibliogràfiques

Autors principals:	Carla Boquimpani, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit, Jaisson André Pagnoncelli Bortolini, Katia Borgia Barbosa Pagnano, Renato Centrone, Vaneuza Funke
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2022-07-01
Col·lecció:	Hematology, Transfusion and Cell Therapy
Matèries:	Practice guideline Leukemia myelogenous chronic BCR-ABL positive Therapeutics
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2531137922000505
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!